# Evaluating the Efficacy and Safety of Cleanser, Serum, and Sunscreen Products for Facial Redness.

> **NCT05961579** · PHASE3 · UNKNOWN · sponsor: **Goldman, Butterwick, Fitzpatrick and Groff** · enrollment: 20 (estimated)

## Conditions studied

- Redness

## Interventions

- **DRUG:** Barrier Renew

## Key facts

- **NCT ID:** NCT05961579
- **Lead sponsor:** Goldman, Butterwick, Fitzpatrick and Groff
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-11
- **Primary completion:** 2023-11-01
- **Final completion:** 2023-11-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05961579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05961579, "Evaluating the Efficacy and Safety of Cleanser, Serum, and Sunscreen Products for Facial Redness.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05961579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*